
AbbVie ordered to pay $3.2 million after retrial of lawsuit claiming low-testosterone drug AndroGel caused heart attack
A federal jury on Monday ordered AbbVie to pay $3.2 million to an Oregon man who claims the testosterone replacement drug AndroGel caused him to suffer a heart attack, a...








